{
    "id": 6786,
    "fullName": "FLT3 I836del",
    "impact": "deletion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FLT3 I836del results in the deletion of an amino acid in the protein kinase domain activation loop of the Flt3 protein at amino acid 836 (PMID: 12663439). I836del results in constitutive phosphorylation of Flt3 and activation of Stat5, Erk signaling, leading to transformation of cultured cells (PMID: 15256420).",
            "references": [
                {
                    "id": 2706,
                    "pubMedId": 15256420,
                    "title": "Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15256420"
                },
                {
                    "id": 2863,
                    "pubMedId": 12663439,
                    "title": "Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12663439"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2322,
        "geneSymbol": "FLT3",
        "terms": [
            "FLT3",
            "CD135",
            "FLK-2",
            "FLK2",
            "STK1"
        ]
    },
    "variant": "I836del",
    "createDate": "05/29/2015",
    "updateDate": "10/04/2018",
    "referenceTranscriptCoordinates": {
        "id": 144515,
        "transcript": "NM_004119",
        "gDna": "chr13:g.28018500_28018502delGAT",
        "cDna": "c.2508_2510delCAT",
        "protein": "p.I836delI",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12171,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tandutinib (CT53518) inhibited phosphorylation of FLT3 and activation of ERK and STAT5, and reduced growth of transformed cells expressing FLT3 I836del in culture (PMID: 15256420).",
            "molecularProfile": {
                "id": 6640,
                "profileName": "FLT3 I836del"
            },
            "therapy": {
                "id": 933,
                "therapyName": "Tandutinib",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2706,
                    "pubMedId": 15256420,
                    "title": "Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15256420"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12172,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rydapt (midostaurin) inhibited phosphorylation of FLT3, ERK, and STAT5, and growth of transformed cells expressing FLT3 I836del in culture (PMID: 17827387).",
            "molecularProfile": {
                "id": 6640,
                "profileName": "FLT3 I836del"
            },
            "therapy": {
                "id": 810,
                "therapyName": "Midostaurin",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10126,
                    "pubMedId": 17827387,
                    "title": "Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17827387"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6640,
            "profileName": "FLT3 I836del",
            "profileTreatmentApproaches": [
                {
                    "id": 5002,
                    "name": "FLT3 Inhibitor",
                    "profileName": "FLT3 I836del"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144516,
            "transcript": "XM_017020486",
            "gDna": "chr13:g.28015186_28015188delCAT",
            "cDna": "c.2506_2508delATG",
            "protein": "p.M836delM",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 144515,
            "transcript": "NM_004119",
            "gDna": "chr13:g.28018500_28018502delGAT",
            "cDna": "c.2508_2510delCAT",
            "protein": "p.I836delI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 144517,
            "transcript": "XM_011535015",
            "gDna": "chr13:g.28015679_28015681delATC",
            "cDna": "c.2506_2508delATG",
            "protein": "p.M836delM",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}